| Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial SV Navarra, RM Guzmán, AE Gallacher, S Hall, RA Levy, RE Jimenez, ... The Lancet 377 (9767), 721-731, 2011 | 2278 | 2011 |
| Treat-to-target in systemic lupus erythematosus: recommendations from an international task force RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ... Annals of the rheumatic diseases 73 (6), 958-967, 2014 | 882 | 2014 |
| Anti-inflammatory and immunosuppressive drugs and reproduction M Østensen, M Khamashta, M Lockshin, A Parke, A Brucato, H Carp, ... Arthritis research & therapy 8, 1-19, 2006 | 715 | 2006 |
| Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients RA Asherson, R Cervera, JC Piette, J Font, JT Lie, A Burcoglu, K Lim, ... Medicine 77 (3), 195-207, 1998 | 714 | 1998 |
| Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study G Singh, JG Fort, JL Goldstein, RA Levy, PS Hanrahan, AE Bello, ... The American journal of medicine 119 (3), 255-266, 2006 | 505 | 2006 |
| Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study RA Levy, VS Vilela, MJ Cataldo, RC Ramos, JLMB Duarte, BR Tura, ... Lupus 10 (6), 401-404, 2001 | 481 | 2001 |
| Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double‐blind, placebo‐controlled trial in asymptomatic antiphospholipid antibody … D Erkan, MJ Harrison, R Levy, M Peterson, M Petri, L Sammaritano, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 469 | 2007 |
| The 2023 ACR/EULAR antiphospholipid syndrome classification criteria M Barbhaiya, S Zuily, R Naden, A Hendry, F Manneville, MC Amigo, ... Arthritis & Rheumatology 75 (10), 1687-1702, 2023 | 445 | 2023 |
| A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS) R Van Vollenhoven, A Voskuyl, G Bertsias, C Aranow, M Aringer, ... Annals of the rheumatic diseases 76 (3), 554-561, 2017 | 422 | 2017 |
| 14th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends D Erkan, CL Aguiar, D Andrade, H Cohen, MJ Cuadrado, A Danowski, ... Autoimmunity reviews 13 (6), 685-696, 2014 | 381 | 2014 |
| Autoimmunity: from bench to bedside [Internet] JM Anaya, Y Shoenfeld, A Rojas-Villarraga, RA Levy, R Cervera El Rosario University Press, 2013 | 290 | 2013 |
| The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th international congress on antiphospholipid antibodies technical task force report on … MM Abreu, A Danowski, DG Wahl, MC Amigo, M Tektonidou, MS Pacheco, ... Autoimmunity reviews 14 (5), 401-414, 2015 | 263 | 2015 |
| Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials MA Petri, RF Van Vollenhoven, J Buyon, RA Levy, SV Navarra, R Cervera, ... Arthritis & Rheumatism 65 (8), 2143-2153, 2013 | 205 | 2013 |
| First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano … BA Pons-Estel, E Bonfa, ER Soriano, MH Cardiel, A Izcovich, F Popoff, ... Annals of the rheumatic diseases 77 (11), 1549-1557, 2018 | 176 | 2018 |
| Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. S Garcia, JH Nascimento, E Bonfa, R Levy, SF Oliveira, AV Tavares, ... The Journal of clinical investigation 93 (2), 718-724, 1994 | 173 | 1994 |
| Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus … V Strand, RA Levy, R Cervera, MA Petri, H Birch, WW Freimuth, ZJ Zhong, ... Annals of the rheumatic diseases 73 (5), 838-844, 2014 | 171 | 2014 |
| Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression A Mahajan, J Amelio, K Gairy, G Kaur, RA Levy, D Roth, D Bass Lupus 29 (9), 1011-1020, 2020 | 160 | 2020 |
| Treatment of pregnant patients with antiphospholipid syndrome A Tincani, W Branch, RA Levy, JC Piette, H Carp, RS Rai, M Khamashta, ... Lupus 12 (7), 524-529, 2003 | 157 | 2003 |
| Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus DJ Wallace, S Navarra, MA Petri, A Gallacher, M Thomas, R Furie, ... Lupus 22 (2), 144-154, 2013 | 139 | 2013 |
| 10 Years of belimumab experience: What have we learnt? RA Levy, T Gonzalez-Rivera, M Khamashta, NL Fox, A Jones-Leone, ... Lupus 30 (11), 1705-1721, 2021 | 114 | 2021 |
Guilherme Ramires de JesúsProfessor Adjunto, Universidade do Estado do Rio de Janeiro. Médico Obstetra, Instituto FernandesEmail được xác minh tại hupe.uerj.br